ZTI-01 (fosfomycin for injection) in the treatment of hospitalized patients with complicated urinary tract infections.

作者: Rodrigo M Burgos , Keith A Rodvold

DOI: 10.2217/FMB-2018-0303

关键词:

摘要: … Given the rise in drug-resistant bacteria, its introduction into the US market has become a … in the USA for the treatment of complicated urinary tract infections and acute pyelonephritis. …

参考文章(35)
Brian D. VanScoy, Jennifer McCauley, Evelyn J. Ellis-Grosse, Olanrewaju O. Okusanya, Sujata M. Bhavnani, Alan Forrest, Paul G. Ambrose, Exploration of the Pharmacokinetic-Pharmacodynamic Relationships for Fosfomycin Efficacy Using an In Vitro Infection Model Antimicrobial Agents and Chemotherapy. ,vol. 59, pp. 7170- 7177 ,(2015) , 10.1128/AAC.04955-14
Ralph M. Turner, Bingcao Wu, Kenneth Lawrence, Judith Hackett, Sudeep Karve, Ozgur Tunceli, Assessment of Outpatient and Inpatient Antibiotic Treatment Patterns and Health Care Costs of Patients with Complicated Urinary Tract Infections Clinical Therapeutics. ,vol. 37, pp. 2037- 2047 ,(2015) , 10.1016/J.CLINTHERA.2015.06.013
F. Docobo-Pérez, G. L. Drusano, A. Johnson, J. Goodwin, S. Whalley, V. Ramos-Martín, M. Ballestero-Tellez, J. M. Rodriguez-Martinez, M. C. Conejo, M. van Guilder, J. Rodríguez-Baño, A. Pascual, W. W. Hope, Pharmacodynamics of Fosfomycin: Insights into Clinical Use for Antimicrobial Resistance Antimicrobial Agents and Chemotherapy. ,vol. 59, pp. 5602- 5610 ,(2015) , 10.1128/AAC.00752-15
Dmitri Iarikov, Ronald Wassel, John Farley, Sumathi Nambiar, Adverse Events Associated with Fosfomycin Use: Review of the Literature and Analyses of the FDA Adverse Event Reporting System Database Infectious Diseases and Therapy. ,vol. 4, pp. 433- 458 ,(2015) , 10.1007/S40121-015-0092-8
Frederick M. Kahan, Jean S. Kahan, Patrick J. Cassidy, Helmut Kropp, THE MECHANISM OF ACTION OF FOSFOMYCIN (PHOSPHONOMYCIN) Annals of the New York Academy of Sciences. ,vol. 235, pp. 364- 386 ,(1974) , 10.1111/J.1749-6632.1974.TB43277.X
Mazen S. Bader, John Hawboldt, Annie Brooks, Management of complicated urinary tract infections in the era of antimicrobial resistance. Postgraduate Medicine. ,vol. 122, pp. 7- 15 ,(2010) , 10.3810/PGM.2010.11.2217
M. Popovic, D. Steinort, S. Pillai, C. Joukhadar, Fosfomycin: an old, new friend? European Journal of Clinical Microbiology & Infectious Diseases. ,vol. 29, pp. 127- 142 ,(2010) , 10.1007/S10096-009-0833-2
Matthew E Falagas, Nikos Roussos, Ioannis D Gkegkes, Petros I Rafailidis, Drosos E Karageorgopoulos, Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies. Expert Opinion on Investigational Drugs. ,vol. 18, pp. 921- 944 ,(2009) , 10.1517/13543780902967624
Kalpana Gupta, Larissa Grigoryan, Barbara Trautner, Urinary Tract Infection Annals of Internal Medicine. ,vol. 167, ,(2012) , 10.7326/AITC201710030